OGINasdaqPharmaceutical PreparationsFiscal year ends September 30

ORGANIGRAM GLOBAL INC.

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 16, 2025

$0.94+0.02 (+1.73%)

Close on Oct 19, 2026

Debt

Borrowings on the balance sheet, Sep 30, 2025

Total debt

C$25.00K

C$25.00K due within a year

Net debt

-C$83.57M

After C$83.59M of cash

Implied interest rate

–

FY2025 interest ÷ average debt

Interest coverage

–

FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, CAD

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Organigram Global's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Organigram Global's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Dec 19, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is OGI.

Revenue growth77.8% · median 15.8%

Gross margin34.8% · median 25.2%

Operating margin-5.9% · median -170.1%

Company	Revenue	Growth
CGC	C$293.63M	+6.8%
OGI	C$259.18M	+77.8%
CPMD	$1.70M	+24.8%
OWPC	$53.43K	–
IMCC	–	–
INCR	–	–

Company

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: September 30
Held by institutions: 5.7%
Auditor: PKF OConnor Davies, LLP
SEC CIK: 1620737

Advertisement
300 × 250